Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-29 @ 8:58 PM
Study NCT ID:
NCT01703468
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2012-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
Sponsor:
Roxane Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OXCA-S600-PVFD-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None